NASDAQ
14.82USD
-1.91 (-11.42%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
7.3B
P/E
—
EPS
—
Beta
1.64
52W range
9.39-69
Day range
14.27–17.01
Open
16.80
Prev close
16.73
Volume
196.8K
Avg volume
125.4K
Dividend
0.00
IPO
2021-07-16
https://www.globenewswire.com/news-release/2026/06/13/3311384/683/en/RGC-EQUITY-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-Regencell-Bioscience-RGC-Investors-of-Securities-Class-Action-Lawsuit-Deadline-on-June-23-2026.html · 6/13/2026-1.00
https://www.newsfilecorp.com/release/300762/INVESTOR-ALERT-Faruqi-Faruqi-LLP-Notifies-Roblox-RBLX-Investors-of-Securities-Class-Action-Deadline-on-August-7-2026 · 6/10/2026-0.80
https://www.newsfilecorp.com/release/300199/WGS-SHAREHOLDER-NOTICE-Faruqi-Faruqi-LLP-Reminds-GeneDx-WGS-Investors-of-Securities-Class-Action-Deadline-on-August-3-2026 · 6/6/2026-0.50
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-futu-holdings-limited-investors-to-inquire-about-securities-class-action-investigation--futu-302789490.html · 6/3/2026
https://www.newsfilecorp.com/release/298933/POET-EQUITY-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-POET-Technologies-POET-Investors-of-Securities-Class-Action-Deadline-on-June-29-2026 · 5/26/2026-0.50
https://www.newsfilecorp.com/release/298612/SRAD-SHAREHOLDER-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-Sportradar-SRAD-Investors-of-Securities-Class-Action-Deadline-on-July-17-2026 · 5/25/2026-0.50
https://www.newsfilecorp.com/release/298446/NUAI-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-New-Era-Energy-Digital-NUAI-Investors-of-Securities-Class-Action-Deadline-on-June-1-2026 · 5/24/2026-0.50
https://www.newsfilecorp.com/release/298448/PHR-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Phreesia-PHR-Investors-of-Securities-Class-Action-Deadline-on-July-13-2026 · 5/24/2026-0.80
https://www.newsfilecorp.com/release/297538/LU-DEADLINE-ALERT-Faruqi-Faruqi-LLP-Reminds-Lufax-LU-Investors-of-Securities-Class-Action-Deadline-on-May-20-2026 · 5/17/2026-1.00
https://www.prnewswire.com/news-releases/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-regencell-bioscience-holdings-limited-and-certain-officers--rgc-302773072.html · 5/15/2026-1.00
https://www.newsfilecorp.com/release/296689/MNDY-SHAREHOLDER-REMINDER-Faruqi-Faruqi-LLP-Reminds-monday.com-MNDY-Investors-of-Securities-Class-Action-Deadline-on-May-11-2026 · 5/10/2026-0.80
https://www.newsfilecorp.com/release/295828/INVESTIGATION-REMINDER-Faruqi-Faruqi-LLP-Continues-Investigation-of-Potential-Securities-Claims-Against-Duolingo-DUOL · 5/5/2026-0.50
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
